LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model
The prototype J-LEAPS T cell vaccine for HER-2/neu breast cancer (J-HER) consists of the murine HER-2/neu66–74 H-2d CD8 T cell epitope covalently attached through a triglycine linker to the J-immune cell binding ligand (ICBL) (human β2 microglobulin38–50 peptide). The J-ICBL was chosen for its poten...
Saved in:
Main Authors: | Ken S. Rosenthal, Sarah Stone, Gary Koski, Daniel H. Zimmerman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2017/3613505 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor
by: Alessia Lamolinara, et al.
Published: (2015-01-01) -
Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67
by: Vandana Puri, et al.
Published: (2011-01-01) -
HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
by: Cathy B. Moelans, et al.
Published: (2009-01-01) -
A New Monoclonal Antibody Demonstrates That Muc4, the Intramembrane Ligand for Erbb2/Her2/Neu, Is Overexpressed in Multiple Carcinomas
by: Jin Zhang, et al.
Published: (2002-01-01) -
The Third Leap Zagreb Index for Trees
by: Jia-Ming Zhu, et al.
Published: (2019-01-01)